238 related articles for article (PubMed ID: 32472525)
1. Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation.
Fenoglio R; Baldovino S; Ferro M; Sciascia S; Rabajoli G; Quattrocchio G; Beltrame G; Naretto C; Rossi D; Alpa M; Barreca A; Papotti MG; Roccatello D
J Nephrol; 2021 Feb; 34(1):231-240. PubMed ID: 32472525
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory profile of renal amyloidosis: A single-center experience.
Engineer DP; Kute VB; Patel HV; Shah PR
Saudi J Kidney Dis Transpl; 2018; 29(5):1065-1072. PubMed ID: 30381502
[TBL] [Abstract][Full Text] [Related]
3. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
[TBL] [Abstract][Full Text] [Related]
5. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
6. Light-chain amyloidosis with renal involvement: renal outcomes and validation of two renal staging systems in the Chinese population.
Zhu Z; Yue C; Sun Y; Li X; Li M
Amyloid; 2019 Dec; 26(4):186-191. PubMed ID: 31339366
[No Abstract] [Full Text] [Related]
7. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis.
Angel-Korman A; Jaberi A; Sanchorawala V; Havasi A
Amyloid; 2020 Mar; 27(1):17-24. PubMed ID: 31595786
[No Abstract] [Full Text] [Related]
8. Clinical features and outcomes of renal amyloidosis in Hong Kong.
Lin RCC; Yuen SK; Cheung SF; Tang HL; Fung SKS
Nephrology (Carlton); 2022 Nov; 27(11):869-876. PubMed ID: 36054582
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis.
Sidiqi MH; Aljama MA; Jevremovic D; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Gonsalves WI; Kumar S; Kapoor P; Kourelis T; Leung N; Hogan WJ; Gertz MA
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2360-2364. PubMed ID: 29964192
[TBL] [Abstract][Full Text] [Related]
10. Value of repeat renal biopsy in the evaluation of AL amyloidosis patients lacking renal response despite of complete hematologic remission: a case report and literature review.
Zhang P; Chen X; Zou Y; Wang W; Feng Y
BMC Nephrol; 2022 Mar; 23(1):127. PubMed ID: 35361145
[TBL] [Abstract][Full Text] [Related]
11. Clinical characterization and outcomes of a cohort of colombian patients with AL Amyloidosis.
Lacouture Fierro JA; Ribero Vargas DA; Sánchez Cano J; Gaviria Jaramillo LM; Perilla Suarez OG; Galvez Cárdenas KM; Ospina Ospina S
Colomb Med (Cali); 2023; 54(3):e2025667. PubMed ID: 38107838
[TBL] [Abstract][Full Text] [Related]
12. Persistence of renal function in a patient diagnosed with concurrent amyloid amyloidosis and immunoglobulin light chain amyloidosis.
Watanabe R; Ito K; Yasuno T; Abe Y; Hamauchi A; Yasunaga T; Sasatomi Y; Hisano S; Saito T; Nakashima H
Nihon Jinzo Gakkai Shi; 2016; 58(5):668-74. PubMed ID: 30375826
[TBL] [Abstract][Full Text] [Related]
13. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcome of primary systemic light-chain amyloidosis in Greece.
Michael M; Kastritis E; Delimpassi S; Michalis E; Repoussis P; Kyrtsonis MC; Katodritou E; Anagnostopoulos N; Zervas K; Dimopoulos MA;
Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):56-61. PubMed ID: 20223730
[TBL] [Abstract][Full Text] [Related]
15. Successful Treatment of Systemic Light Chain Amyloidosis with Liver Involvement using Low-Frequency Daratumumab: A Case Report.
Meng X; He J; Cheng F; Yan H; Zhu C; Guo X; Li Y; Cai Z; He D
Am J Case Rep; 2024 Jan; 25():e942534. PubMed ID: 38229422
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.
Batalini F; Econimo L; Quillen K; Sloan JM; Sarosiek S; Brauneis D; Havasi A; Stern L; Dember LM; Sanchorawala V
Biol Blood Marrow Transplant; 2018 Jan; 24(1):127-132. PubMed ID: 28865972
[TBL] [Abstract][Full Text] [Related]
17. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.
Comenzo RL; Vosburgh E; Falk RH; Sanchorawala V; Reisinger J; Dubrey S; Dember LM; Berk JL; Akpek G; LaValley M; O'hara C; Arkin CF; Wright DG; Skinner M
Blood; 1998 May; 91(10):3662-70. PubMed ID: 9573002
[TBL] [Abstract][Full Text] [Related]
18. Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition.
Muchtar E; Dispenzieri A; Lacy MQ; Buadi FK; Kapoor P; Hayman SR; Gonsalves W; Warsame R; Kourelis TV; Chakraborty R; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Rajkumar SV; Dingli D; Leung N; Kyle RA; Kumar SK; Gertz MA
Ann Med; 2017 Nov; 49(7):545-551. PubMed ID: 28271734
[TBL] [Abstract][Full Text] [Related]
19. How I Approach Light Chain Amyloidosis.
Chowdhury RB; Leung N
G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007836
[TBL] [Abstract][Full Text] [Related]
20. Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report.
Al-Zoairy R; Viveiros A; Zoller H; Schneeberger S; Oberhuber G; Gunsilius E; Tilg H; Wolf D; Rudzki JD
J Med Case Rep; 2020 Oct; 14(1):201. PubMed ID: 33099313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]